The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(5-(2,4,5-Trifluoro-3-hydroxybenzoyl)thiophen-2-yl)phenyl sulfamate ID: ALA4584367
PubChem CID: 122653046
Max Phase: Preclinical
Molecular Formula: C17H10F3NO5S2
Molecular Weight: 429.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)Oc1ccc(-c2ccc(C(=O)c3cc(F)c(F)c(O)c3F)s2)cc1
Standard InChI: InChI=1S/C17H10F3NO5S2/c18-11-7-10(14(19)17(23)15(11)20)16(22)13-6-5-12(27-13)8-1-3-9(4-2-8)26-28(21,24)25/h1-7,23H,(H2,21,24,25)
Standard InChI Key: VEOHVGGIOZDGJG-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
41.0701 -26.3854 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.0742 -25.5682 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
40.3644 -25.9732 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.7952 -26.4142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7941 -27.2338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5021 -27.6427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2118 -27.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2090 -26.4106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5004 -26.0054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4979 -25.1882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2044 -24.7775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7890 -24.7817 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.9505 -25.1099 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
37.4955 -24.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0847 -23.7944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2860 -23.9668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0861 -27.6418 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.3067 -24.5823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0874 -26.0058 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.9202 -27.6408 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
35.5019 -28.4599 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
38.6379 -25.3279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4483 -25.4096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9253 -24.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5860 -24.0012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7765 -23.9232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7385 -24.8277 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.8886 -25.6527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
9 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 11 2 0
5 17 1 0
14 18 1 0
4 19 1 0
7 20 1 0
6 21 1 0
18 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 18 1 0
24 27 1 0
27 2 1 0
2 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 429.40Molecular Weight (Monoisotopic): 428.9952AlogP: 3.35#Rotatable Bonds: 5Polar Surface Area: 106.69Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.18CX Basic pKa: ┄CX LogP: 3.76CX LogD: 2.59Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.48Np Likeness Score: -0.73
References 1. Abdelsamie AS, Salah M, Siebenbürger L, Hamed MM, Börger C, van Koppen CJ, Frotscher M, Hartmann RW.. (2019) Development of potential preclinical candidates with promising in vitro ADME profile for the inhibition of type 1 and type 2 17β-Hydroxysteroid dehydrogenases: Design, synthesis, and biological evaluation., 178 [PMID:31176098 ] [10.1016/j.ejmech.2019.05.084 ]